Cambridge Investment Research Advisors, Inc. Tandem Diabetes Care Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 13,667 shares of TNDM stock, worth $503,355. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,667

Previous 12,988 5.23%

Holding current value

$503,355

Previous $523,000 10.9%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$35.21 - $47.3 $23,907 - $32,116	679 Added 5.23%	13,667 $580,000
Q2 2024 Jul 26, 2024	SELL	$30.43 - $53.43 $9,129 - $16,029	-300 Reduced 2.26%	12,988 $523,000
Q1 2024 Apr 24, 2024	BUY	$22.09 - $35.41 $293,531 - $470,528	13,288 New	13,288 $471,000
Q1 2023 May 11, 2023	BUY	$35.86 - $46.5 $5,737 - $7,440	160 Added 2.57%	6,388 $259,000
Q4 2022 Feb 08, 2023	BUY	$35.49 - $56.15 $1,739 - $2,751	49 Added 0.79%	6,228 $280,000
Q3 2022 Oct 17, 2022	BUY	$43.76 - $68.97 $13,128 - $20,691	300 Added 5.1%	6,179 $295,000
Q2 2022 Jul 13, 2022	SELL	$53.22 - $123.09 $34,060 - $78,777	-640 Reduced 9.82%	5,879 $347,000
Q1 2022 May 12, 2022	SELL	$101.89 - $150.09 $50,945 - $75,045	-500 Reduced 7.12%	6,519 $758,000
Q4 2021 Feb 03, 2022	BUY	$118.18 - $153.21 $6,499 - $8,426	55 Added 0.79%	7,019 $1.06 Million
Q3 2021 Nov 02, 2021	SELL	$93.51 - $129.4 $18,702 - $25,880	-200 Reduced 2.79%	6,964 $831,000
Q2 2021 Aug 10, 2021	SELL	$77.0 - $100.19 $55,979 - $72,838	-727 Reduced 9.21%	7,164 $697,000
Q1 2021 May 07, 2021	BUY	$81.28 - $104.34 $26,903 - $34,536	331 Added 4.38%	7,891 $696,000
Q4 2020 Feb 04, 2021	BUY	$86.4 - $121.75 $367,027 - $517,194	4,248 Added 128.26%	7,560 $723,000
Q3 2020 Oct 29, 2020	BUY	$95.43 - $116.09 $31,587 - $38,425	331 Added 11.1%	3,312 $375,000
Q2 2020 Jul 27, 2020	BUY	$60.05 - $98.92 $179,009 - $294,880	2,981 New	2,981 $294,000
Q4 2019 Feb 04, 2020	SELL	$53.13 - $71.19 $540,916 - $724,785	-10,181 Closed	0 $0
Q3 2019 Nov 06, 2019	BUY	$57.11 - $73.3 $7,481 - $9,602	131 Added 1.3%	10,181 $600,000
Q3 2019 Oct 28, 2019	BUY	$57.11 - $73.3 $1,142 - $1,466	20 Added 0.2%	10,050 $592,000
Q2 2019 Aug 15, 2019	SELL	$54.41 - $71.7 $138,092 - $181,974	-2,538 Reduced 20.19%	10,030 $0
Q1 2019 May 08, 2019	BUY	$32.25 - $73.56 $405,318 - $924,502	12,568 New	12,568 $0
Q4 2018 Feb 05, 2019	SELL	$28.45 - $40.65 $291,897 - $417,069	-10,260 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$21.39 - $51.17 $219,461 - $525,004	10,260 New	10,260 $0

Others Institutions Holding TNDM

# of Institutions

359

Shares Held

72.2M

Call Options Held

3.36M

Put Options Held

229K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.37B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Tandem Diabetes Care Inc Transaction History